Schedule 13D ownership disclosure

VITALITY BIOPHARMA

COMMON STOCK · CUSIP: 92849B107

Event date: 2025-09-23

Filing-level shares
26,645,789.00
Percent of class
23.73%
  • Joseph E. LoContiReported CIK 0001025708

    Shares: 26,645,789.00 · Class: 23.73%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-014941
Form type
SCHEDULE 13D/A
Filer
LoConti Joseph E.
CIK
CIK 1025708
Filed
Sep 25, 2025
Reporting period
Sep 23, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub